You are here

Study Evaluating Etanercept Treatment of Patients With Ankylosing Spondylitis

Last updated on March 14, 2019

FOR MORE INFORMATION
Study Location
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Ankylosing Spondylitis
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18-70 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Diagnosis of AS (defined by Modified New York Criteria for Ankylosing Spondylitis).

- Active AS (defined by the average of scores on the visual analog scale [VAS] of ≥ 30
for duration and intensity of morning stiffness and by 2 of the following: VAS for
patient global assessment ≥ 30; average of VAS for nocturnal and total pain ≥ 30;
BASFI ≥ 30 (all scores on a scale of 0 to 100).

- 18 to 70 years of age.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Complete ankylosis (fusion) of spine.

- Previous receipt of etanercept, antibody to tumour necrosis factor alpha (TNF?), or
other TNF? inhibitors.

- Use of disease-modifying antirheumatic drugs (DMARDs) other than hydroxychloroquine,
sulphasalazine, or methotrexate within 4 weeks of baseline.

NCT00421915
Pfizer
Completed
Study Evaluating Etanercept Treatment of Patients With Ankylosing Spondylitis

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Ankylosing Spondylitis
NCT03502616
All Genders
18+
Years
Multiple Sites
Crohn Desease, Ulcerative Colitis, Rheumatoid Arthritis, Ankylosing Spondylitis, Psoriatic Arthritis
NCT02925338
All Genders
6+
Years
Multiple Sites

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now